Uncovering novel endocannabinoidome-gut microbiome-brain axis-based therapeutic targets in a Fragile X Syndrome mouse model
Antonella Campanale(McGill University), Vincenzo Di Marzo(Natural Sciences and Engineering Research Council of Canada), M. Mallar Chakravarty(Douglas Mental Health University Institute), Nahum Sonenberg(McGill University), Hayatte-Dounia Mir(Université Paris-Saclay), Cristoforo Silvestri(Université Laval), Nicolas Flamand(Natural Sciences and Engineering Research Council of Canada), Elizabeth Dumais(Lung Institute), Ilse Gantois(McGill University), Antonio Inserra(South Australian Health and Medical Research Institute), Nadeem Siddiqui(Glasgow Royal Infirmary), Gabriella Gobbi(McGill University)
Progress in Neuro-Psychopharmacology and Biological Psychiatry
December 11, 2025
Cited by 1
Related Papers
Upstream and downstream of mTOR
|Genes & Development|2004|4.2k
Brain charts for the human lifespan
|Nature|2022|1.8k
Regulation of translation initiation by FRAP/mTOR
|Genes & Development|2001|1.5k
Translational control in stress and apoptosis
|Nature Reviews Molecular Cell Biology|2005|1.4k
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism
|Genes & Development|1999|1.3k